Simon Farrell

Chief Commercial OfficerTrevi Therapeutics, Inc. (TRVI) · full profile →Form 4 · filed Mar 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$549K
Net Open-Market Flow
-$549K
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Sell(S)4K$7.15$31K77K
Mar 10, 2025Option exercise(M)31K$0.51$16K158K
Mar 10, 2025Option exercise(M)64K$3.91$250K127K
Mar 10, 2025Option exercise(M)18K$3.21$56K63K
Mar 10, 2025Sell(S)77K$6.73$518K81K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Option exercise(M)64K$011K
Mar 10, 2025Option exercise(M)18K$00
Mar 10, 2025Grant(A)38K$038K
Mar 10, 2025Option exercise(M)31K$019K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-037880) within minutes of acceptance. Every field above traces to the original document. Verify it directly: